Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
! colspan="2" rowspan="2" |Mechanism | ! colspan="2" rowspan="2" |Mechanism | ||
! colspan="12" |Clinical manifestations | ! colspan="12" |Clinical manifestations | ||
! colspan=" | ! colspan="11" |Laboratory Findings | ||
! rowspan="3" |'''Gold standard''' | |||
! rowspan="3" |Associated findings | |||
|- | |- | ||
! | ! | ||
Line 25: | Line 27: | ||
!Immunochemistry | !Immunochemistry | ||
!Blood work | !Blood work | ||
!Biospy | ! rowspan="2" |Biospy | ||
! rowspan="2" |Other | |||
|- | |- | ||
! | ! | ||
Line 44: | Line 47: | ||
!Hb | !Hb | ||
!Plt | !Plt | ||
! | ! | ||
! | ! | ||
Line 122: | Line 124: | ||
====Anaplastic:==== | ====Anaplastic:==== | ||
*Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells of Hodgkin's lymphoma or Anaplastic Large cell Lymphoma. | *Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells of Hodgkin's lymphoma or Anaplastic Large cell Lymphoma. | ||
| | |||
| | |||
| | |||
|- | |- | ||
| | | | ||
Line 153: | Line 158: | ||
* [[Seizures]] | * [[Seizures]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 225: | Line 233: | ||
:** The ''stars'' in the pattern are tingible-body macrophages (macrophages containing [[apoptotic]] tumor cells) | :** The ''stars'' in the pattern are tingible-body macrophages (macrophages containing [[apoptotic]] tumor cells) | ||
:** The tumour cells are the ''sky'' | :** The tumour cells are the ''sky'' | ||
| | |||
| | |||
| | |||
|- | |- | ||
| rowspan="25" |B cell lymphoma | | rowspan="25" |B cell lymphoma | ||
Line 281: | Line 292: | ||
* Germinal centers filled by small-to-medium atypical lymphocytes. | * Germinal centers filled by small-to-medium atypical lymphocytes. | ||
* Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease. | * Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease. | ||
| | |||
| | |||
| | |||
|- | |- | ||
|[[Nodal marginal zone B-cell lymphoma]] | |[[Nodal marginal zone B-cell lymphoma]] | ||
Line 326: | Line 340: | ||
* Follicular cells in reactive zone | * Follicular cells in reactive zone | ||
* Centrocyte like cells in marginal zone lymphoma | * Centrocyte like cells in marginal zone lymphoma | ||
| | |||
| | |||
| | |||
|- | |- | ||
|[[Splenic marginal zone lymphoma]] | |[[Splenic marginal zone lymphoma]] | ||
Line 369: | Line 386: | ||
* '''Bone Marrow Biopsy''' | * '''Bone Marrow Biopsy''' | ||
** Splenic marginal zone lymphoma in [[bone marrow]] displays a nodular pattern with morphology similar to what is observed in the splenic [[hilar]] [[lymph nodes]]. | ** Splenic marginal zone lymphoma in [[bone marrow]] displays a nodular pattern with morphology similar to what is observed in the splenic [[hilar]] [[lymph nodes]]. | ||
| | |||
| | |||
| | |||
|- | |- | ||
|[[Hairy cell leukemia]] | |[[Hairy cell leukemia]] | ||
Line 428: | Line 448: | ||
:* Central round [[nucleus]] | :* Central round [[nucleus]] | ||
:* Peri-nuclear clearing ("water-clear rim" appearance) | :* Peri-nuclear clearing ("water-clear rim" appearance) | ||
| | |||
| | |||
| | |||
|- | |- | ||
|[[Multiple myeloma|Plasma cell myeloma]] | |[[Multiple myeloma|Plasma cell myeloma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 457: | Line 483: | ||
|- | |- | ||
|[[Chronic lymphocytic leukemia]] / [[Chronic lymphocytic leukemia|small lymphocytic lymphoma]] | |[[Chronic lymphocytic leukemia]] / [[Chronic lymphocytic leukemia|small lymphocytic lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 484: | Line 513: | ||
|- | |- | ||
|[[Monoclonal B-cell lymphocytosis]] | |[[Monoclonal B-cell lymphocytosis]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 511: | Line 543: | ||
|- | |- | ||
|[[B-cell prolymphocytic leukemia]] | |[[B-cell prolymphocytic leukemia]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 538: | Line 573: | ||
|- | |- | ||
|[[Waldenström's macroglobulinemia|Waldenström's macroglubulinemia]] | |[[Waldenström's macroglobulinemia|Waldenström's macroglubulinemia]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 565: | Line 603: | ||
|- | |- | ||
|[[Monoclonal gammopathy of undetermined significance]] (MGUS) | |[[Monoclonal gammopathy of undetermined significance]] (MGUS) | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 592: | Line 633: | ||
|- | |- | ||
|[[Heavy chain disease]] | |[[Heavy chain disease]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 619: | Line 663: | ||
|- | |- | ||
|Solitary plasmacytoma of bone | |Solitary plasmacytoma of bone | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 646: | Line 693: | ||
|- | |- | ||
|Extraosseous plasmacytoma | |Extraosseous plasmacytoma | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 673: | Line 723: | ||
|- | |- | ||
|Monoclonal immunoglobulin deposition diseases | |Monoclonal immunoglobulin deposition diseases | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 700: | Line 753: | ||
|- | |- | ||
|Extranodal marginal zone lymphoma of [[MALT lymphoma|mucosa-associated lymphoid tissue]] (MALT lymphoma) | |Extranodal marginal zone lymphoma of [[MALT lymphoma|mucosa-associated lymphoid tissue]] (MALT lymphoma) | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 727: | Line 783: | ||
|- | |- | ||
|Large B-cell lymphoma with IRF4 rearrangement | |Large B-cell lymphoma with IRF4 rearrangement | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 754: | Line 813: | ||
|- | |- | ||
|[[Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle center lymphoma]] | |[[Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle center lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 781: | Line 843: | ||
|- | |- | ||
|T-cell/histiocyte-rich large B-cell lymphoma | |T-cell/histiocyte-rich large B-cell lymphoma | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 808: | Line 873: | ||
|- | |- | ||
|[[Lymphomatoid granulomatosis]] | |[[Lymphomatoid granulomatosis]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 835: | Line 903: | ||
|- | |- | ||
|[[Primary mediastinal large B-cell lymphoma|Primary mediastinal (thymic) large B-cell lymphoma]] | |[[Primary mediastinal large B-cell lymphoma|Primary mediastinal (thymic) large B-cell lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 862: | Line 933: | ||
|- | |- | ||
|[[Intravascular large B-cell lymphoma]] | |[[Intravascular large B-cell lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 889: | Line 963: | ||
|- | |- | ||
|ALK1 large B-cell lymphoma | |ALK1 large B-cell lymphoma | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 916: | Line 993: | ||
|- | |- | ||
|Plasmablastic lymphoma | |Plasmablastic lymphoma | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 943: | Line 1,023: | ||
|- | |- | ||
|[[Primary effusion lymphoma]] | |[[Primary effusion lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 970: | Line 1,053: | ||
|- | |- | ||
|High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | |High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 1,023: | Line 1,109: | ||
| | | | ||
* Cutaneous manifestaions | * Cutaneous manifestaions | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 1,038: | Line 1,127: | ||
| | | | ||
|- | |- | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 1,065: | Line 1,157: | ||
| | | | ||
|- | |- | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 1,092: | Line 1,187: | ||
| | | | ||
|- | |- | ||
| | |||
| | |||
| | |||
| | | | ||
| | | | ||
Line 1,173: | Line 1,271: | ||
:* Large granular lymphocyte count greater than 2.0 × 109/L | :* Large granular lymphocyte count greater than 2.0 × 109/L | ||
:* Lymphocytosis (typically 2-20x109/L) | :* Lymphocytosis (typically 2-20x109/L) | ||
| | |||
| | |||
| | |||
|- | |- | ||
|[[Subcutaneous panniculitis-like T-cell lymphoma]] | |[[Subcutaneous panniculitis-like T-cell lymphoma]] | ||
| | |||
| | |||
| | |||
| | | | ||
| | | |
Revision as of 19:00, 28 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Laboratory Findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | CBC | PBS | LFT | Immunochemistry | Blood work | Biospy | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional b symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
Diffuse large B-cell lymphoma] | Classified into 2 subtypes based on gene expression profiles:
|
|
|
|
|
Centroblastic
Immunoblastic::
Anaplastic:
|
|||||||||||||||||||||||
Follicular lymphoma |
|
|
|||||||||||||||||||||||||||
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||||||||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
|
CBC
|
|
||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Plasma cell myeloma | |||||||||||||||||||||||||||||
Chronic lymphocytic leukemia / small lymphocytic lymphoma | |||||||||||||||||||||||||||||
Monoclonal B-cell lymphocytosis | |||||||||||||||||||||||||||||
B-cell prolymphocytic leukemia | |||||||||||||||||||||||||||||
Waldenström's macroglubulinemia | |||||||||||||||||||||||||||||
Monoclonal gammopathy of undetermined significance (MGUS) | |||||||||||||||||||||||||||||
Heavy chain disease | |||||||||||||||||||||||||||||
Solitary plasmacytoma of bone | |||||||||||||||||||||||||||||
Extraosseous plasmacytoma | |||||||||||||||||||||||||||||
Monoclonal immunoglobulin deposition diseases | |||||||||||||||||||||||||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | |||||||||||||||||||||||||||||
Large B-cell lymphoma with IRF4 rearrangement | |||||||||||||||||||||||||||||
Primary cutaneous follicle center lymphoma | |||||||||||||||||||||||||||||
T-cell/histiocyte-rich large B-cell lymphoma | |||||||||||||||||||||||||||||
Lymphomatoid granulomatosis | |||||||||||||||||||||||||||||
Primary mediastinal (thymic) large B-cell lymphoma | |||||||||||||||||||||||||||||
Intravascular large B-cell lymphoma | |||||||||||||||||||||||||||||
ALK1 large B-cell lymphoma | |||||||||||||||||||||||||||||
Plasmablastic lymphoma | |||||||||||||||||||||||||||||
Primary effusion lymphoma | |||||||||||||||||||||||||||||
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | |||||||||||||||||||||||||||||
T cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
T-cell granular lymphocytic leukemia |
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following: |
|
|
|
||||||||||||||||||||||||
Subcutaneous panniculitis-like T-cell lymphoma |